Home

ενέργεια Απαρτίζω Απογοήτευση ioannis panagopoulos oslo hospital email Βάτραχος Επιθετικός Σταματήστε από

Ιωάννης Παναγόπουλος, Ασφαλιστικός & Επενδυτικός Σύμβουλος - Chrismos-ike
Ιωάννης Παναγόπουλος, Ασφαλιστικός & Επενδυτικός Σύμβουλος - Chrismos-ike

Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for  Cancer Genetics and Informatics | Research profile
Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for Cancer Genetics and Informatics | Research profile

Ιωάννης Παναγόπουλος, Ασφαλιστικός & Επενδυτικός Σύμβουλος - Chrismos-ike
Ιωάννης Παναγόπουλος, Ασφαλιστικός & Επενδυτικός Σύμβουλος - Chrismos-ike

Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for  Cancer Genetics and Informatics | Research profile
Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for Cancer Genetics and Informatics | Research profile

Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors:  site-specific cytogenetic evolution as evidence of pa
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pa

Interstitial Deletions Generating Fusion Genes | Cancer Genomics &  Proteomics
Interstitial Deletions Generating Fusion Genes | Cancer Genomics & Proteomics

Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for  Cancer Genetics and Informatics | Research profile
Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for Cancer Genetics and Informatics | Research profile

Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for  Cancer Genetics and Informatics | Research profile
Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for Cancer Genetics and Informatics | Research profile

Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor  | Journal of Medicinal Chemistry
Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor | Journal of Medicinal Chemistry

Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for  Cancer Genetics and Informatics | Research profile
Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for Cancer Genetics and Informatics | Research profile

Cancers | Free Full-Text | A Small-Molecule Tankyrase Inhibitor Reduces  Glioma Stem Cell Proliferation and Sphere Formation
Cancers | Free Full-Text | A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation

PDF) NDRG1-PLAG1 and TRPS1-PLAG1 fusion genes in chondroid syringoma
PDF) NDRG1-PLAG1 and TRPS1-PLAG1 fusion genes in chondroid syringoma

Chronic Expanding Hematoma with a t(11;19)(q13;q13) Chromosomal  Translocation | Anticancer Research
Chronic Expanding Hematoma with a t(11;19)(q13;q13) Chromosomal Translocation | Anticancer Research

Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor  | Journal of Medicinal Chemistry
Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor | Journal of Medicinal Chemistry

Chromosome Translocation t(10;19)(q26;q13) in a CIC-sarcoma | In Vivo
Chromosome Translocation t(10;19)(q26;q13) in a CIC-sarcoma | In Vivo

Novel fusion genes and chimeric transcripts in ependymal tumors - Olsen -  2016 - Genes, Chromosomes and Cancer - Wiley Online Library
Novel fusion genes and chimeric transcripts in ependymal tumors - Olsen - 2016 - Genes, Chromosomes and Cancer - Wiley Online Library

Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for  Cancer Genetics and Informatics | Research profile
Ioannis PANAGOPOULOS | PhD | Oslo University Hospital, Oslo | Institute for Cancer Genetics and Informatics | Research profile

Functional temozolomide sensitivity testing of patient-specific  glioblastoma stem cell cultures is predictive of clinical outcom
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcom

Cancers | Free Full-Text | Endometrial Carcinoma: Molecular Cytogenetics  and Transcriptomic Profile
Cancers | Free Full-Text | Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile

Genetic Characterization of Myoid Hamartoma of the Breast | Cancer Genomics  & Proteomics
Genetic Characterization of Myoid Hamartoma of the Breast | Cancer Genomics & Proteomics

The “Grep” Command But Not FusionMap, FusionFinder or ChimeraScan Captures  the CIC-DUX4 Fusion Gene from Whole Transcriptome Sequencing Data on a  Small Round Cell Tumor with t(4;19)(q35;q13) | PLOS ONE
The “Grep” Command But Not FusionMap, FusionFinder or ChimeraScan Captures the CIC-DUX4 Fusion Gene from Whole Transcriptome Sequencing Data on a Small Round Cell Tumor with t(4;19)(q35;q13) | PLOS ONE

Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors:  site-specific cytogenetic evolution as evidence of pa
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pa

PDF) Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With  ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a  Child Treated for Acute Myeloid Leukemia Caused by  t(9;11)(p21;q23)/KMT2A-MLLT3
PDF) Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3

Genetic Characterization of Myoid Hamartoma of the Breast | Cancer Genomics  & Proteomics
Genetic Characterization of Myoid Hamartoma of the Breast | Cancer Genomics & Proteomics

Bodil Bjerkehagen - Institute of Clinical Medicine
Bodil Bjerkehagen - Institute of Clinical Medicine